Owing to the diversity of cancer types and the spatiotemporal heterogeneity of tumour signals, high-resolution imaging of occult malignancy is challenging. 18 F-fluorodeoxyglucose positron emission tomography allows for near-universal cancer detection, yet in many clinical scenarios it is hampered by false positives. Here, we report a method for the amplification of imaging contrast in tumours via the temporal integration of the imaging signals triggered by tumour acidosis. This method exploits the catastrophic disassembly, at the acidic pH of the tumour milieu, of pH-sensitive positron-emitting neutral copolymer micelles into polycationic polymers, which are then internalized and retained by the cancer cells. Positron emission tomography imaging of the 64 Cu-labelled polymers detected small occult tumours (10-20 mm 3 ) in the brain, head, neck and breast of mice at much higher contrast than 18 F-fluorodeoxyglucose, 11 C-methionine and pH-insensitive 64 Cu-labelled nanoparticles. We also show that the pH-sensitive probes reduce false positive detection rates in a mouse model of non-cancerous lipopolysaccharide-induced inflammation. This macromolecular strategy for integrating tumour acidosis should enable improved cancer detection, surveillance and staging.
C ancer exhibits diverse genetic and histological differences from normal tissues 1 . Molecular characterization of these differences is useful to stratify patients towards personalized therapy. However, the strategy may not serve as a broad diagnostic tool because genetic/phenotypic biomarkers are expressed in a subset of patients, and significant overlap with normal tissues exists 2, 3 . Deregulated energetics are hallmarks of cancer that occur across many types of cancer 4 . Elevated glucose metabolism in cancer cells has long been associated with aerobic glycolysis, where cancer cells preferentially take up glucose and convert it into lactic acid 5 . More recent studies using 13 C-labelled glucose in lung cancer patients further show accelerated oxidative phosphorylation in addition to glycolysis as a cancer cell mechanism for growth and proliferation 6 . The clinical significance of the glucose metabolism is manifested by the widespread use of 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) 7 , where FDG-a radiolabelled glucose analogue-is selectively taken up by overexpressed glucose transporters and trapped inside the cancer cells after phosphorylation by hexokinase for PET detection 8 .
Despite broad clinical adoption, FDG has many well-described pitfalls [9] [10] [11] [12] [13] [14] [15] [16] , including relatively high false rates, depending on tumour size and variable levels of FDG uptake in tumours and normal tissues. High physiological uptake of FDG typically occurs in the brain, heart, kidneys and urinary tract, obscuring the tumour signal from areas adjacent to these tissues 11 . In head and neck cancer, high FDG uptake in the Waldeyer's ring (nasopharyngeal, palatine and lingual tonsils), salivary glands, striated muscle or brown fat, and inflammation/infection all contribute to false positive signals 17, 18 . For tumours <1 cm, inadequate accumulation of FDG in tumours over the surrounding normal tissues often leads to false negatives 9, 10, 15, 19 . In addition, skull base tumours in the vicinity of highly metabolic brain parenchyma or oropharyngeal and nasopharyngeal cancers in FDG-avid tonsillar tissue, may yield false negative diagnoses [20] [21] [22] [23] . The variability of FDG uptake, overlap in retention, and temporal fluctuations in metabolism for both normal and tumour tissues significantly limit the accuracy of FDG-PET in cancer detection.
Previously, we reported an indocyanine green (ICG)-encoded ultra-pH-sensitive (UPS) nanoprobe for the broad detection of a wide range of solid cancers by near-infrared fluorescence imaging 24 . This optical tracer exploits the phase transition of the polymers to quench and unquench the fluorescence of dyes conjugated to the hydrophobic portion of the polymers. The optical output is discrete (all on or off with no intermediate values), leading to the high specificity and sensitivity in tumour detection. However, it was unclear whether the phase transition behaviour of the polymers could be harnessed to generate a response or output other than fluorescence. In the tumour milieu, irreversible capture and integration of polycationic unimers on pH activation of neutral circulating micelles can lead to an increase in the polymer dose in acidotic tumours over the surrounding normal tissues. Based on this insight, we hypothesized that the catastrophic phase transition responsible for the binary fluorescence response could be further exploited to achieve binary tumour-specific tissue retention or capture of the activated nanoprobes. Temporal integration of this activated and captured signal can provide signal amplification in only tumours, to overcome the spatiotemporal limitations of FDG. To test this hypothesis, we synthesized a positron-emitting radionuclide ( 64 Cu; t 1/2 = 12.7 h)-encoded UPS nanosensor with dual PET and fluorescence functions. PET imaging using 64 Cu-UPS showed clear detection of occult malignancy in the brain, head and neck, and breast over conventional FDG. Capture of polymers within tumours on activation represents a second output (in addition to fluorescence) that can be exploited for non-invasive imaging of cancer nodules by PET.
results
Synthesis of the 64 Cu-UPS 6.9 nanosensor. 1,4,7-triazacyclononane-N,N′,N'′-trisacetic acid (NOTA)-and ICG-conjugated poly(ethylene glycol)-b-poly(ethylpropylaminoethyl methacrylate) (PEG-b-PEPA) copolymer (also known as UPS 6.9 for pH transition at 6.9) was synthesized via the atom transfer radical polymerization method ( Fig. 1a) 25 . The average numbers of NOTA and ICG per copolymer were determined to be two and one, respectively. After polymer synthesis, 64 Cu chelation to NOTA was carried out at 37 °C and pH 6.5 for 15 min to ensure fully dissociated unimers for efficient copper binding (95%; Fig. 1b ). After 64 Cu labelling, the solution was brought back to pH 7.4 in sodium carbonate buffer to form micelle nanoparticles (32.7 ± 1.6 nm) ( Fig. 1c ). Removal of unbound 64 CuCl 2 and the 64 Cu-NOTA complex was achieved by centrifugal membrane filtration three times with a molecular weight cutoff of 100 kD. The specific activity of the 64 Cu-UPS nanosensor is 5.5 mCi mg −1 (per mass unit) or 165 Ci mmol −1 for molar activity (~6% NOTA on the UPS polymers were labelled with 64 Cu to match the optimum dose for fluorescence imaging). The resulting 64 Cu-UPS nanosensor was stable in the mouse serum within 48 h, as determined by radio thin-layer chromatography (TLC) and fluorescence assays ( Supplementary  Fig. 1 ). Lowering the pH below the transition pH (6.9) led to micelle dissociation into unimers (8.4 ± 0.2 nm). For comparison, NOTA-conjugated poly(ethylene glycol)-b-poly(d,l-lactic acid) (PEG-PLA) nanoparticles of a similar size (32.0 ± 2.4 nm) were also synthesized as a non-pH-sensitive nanosensor control ( Supplementary Fig. 2 ).
Irreversible activation of 64 Cu-UPS 6.9 in biological milieu. In aqueous saline solution (protein free), UPS 6.9 copolymers undergo 'reversible' micelle assembly/disassembly across a narrow pH span (<0.2 pH; Fig. 2a ,b). The protonation process is highly cooperative with a Hill coefficient of 38 ( Fig. 2c ). Along the pH titration coordinate, nanophase segregation (that is, micellization) rendered a bistable-state solution consisting of highly protonated unimers in solution versus neutral copolymers in micelles ( Fig. 2d ). This all-ornothing protonation phenotype without the intermediate states is a hallmark of positive cooperativity 26, 27 . The divergent physical properties of the neutral PEGylated micelles and polycationic unimers account for the molecular basis of capture and integration mechanism in the biological system.
In biological milieu, serum protein binding can 'irreversibly' arrest UPS copolymers in the dissociated unimer state on pH activation of PEGylated micelles ( Fig. 3a) . We examined the reversibility of the UPS 6.9 nanoprobes in the presence or absence of 40 mg ml −1 human serum albumin (HSA) (Fig. 3b ). The results show that in the absence of HSA, UPS 6.9 fluorescence intensity returned to the base level after the pH was reversed from 6.5 to 7.4 multiple times. In contrast, in the presence of HSA, the fluorescence intensity was kept at the 'on' state after pH reversal. These data suggest that the nanoprobe response can be drastically different in the biological environment compared with pristine buffer solutions. This irreversible characteristic contributes to the capture of persistent but fluctuating tumour acidotic signals into stabilized output. 64 Cu-UPS 6.9 nanoprobes before (left) and after centrifugation purification (right). The labelling efficiency was measured with saline as the developing eluent, and was shown to be more than 95%. c, Dynamic light scattering analysis of UPS 6.9 nanoprobes at pH 7.4 and 6.5 (above and below the pH transition threshold, respectively).
Irreversible capture and uptake of 64 Cu-UPS 6.9 . To investigate whether acidic pH can impact nanoprobe uptake inside cancer cells, we incubated 64 Cu-UPS 6.9 with HN5 head and neck cancer cells in DMEM medium at pH 6.5 and 7.4. To mimic the physiological environment, 40 mg ml −1 HSA was added to the medium. For comparison, 64 Cu-PEG-PLA nanoparticles were used as a non-pHsensitive control. HN5 cells were incubated with the same dose of either nanoparticle (25 μg ml −1 ) for different time periods. Then, the radioactive medium was replaced and washed with medium without the tracers. Autoradiography images of HN5 cells from the 96-well plate show pH-dependent uptake of 64 Cu-UPS 6.9. At pH 6.5, increased amounts of positron signals were detected over time, leading to an approximately fivefold increase in cell uptake at 1 h over that at pH 7.4 ( Fig. 3c,d and Supplementary Figs. 3 and 4 ). Albuminmediated unimer uptake was investigated by pretreating UPS nanoprobes at pH 6.5 in the presence of HSA. The pH was then brought back to 7.4. It was found that 50% of polymer uptake occurred in HN5 cells at pH 6.5 ( Supplementary Fig. 5 ). HN5 cells incubated with non-pH-sensitive 64 Cu-PEG-PLA micelles did not show any observable pH dependence in radioactivity signals, and the cell uptake remained low at both pH levels, consistent with the stealth properties of PEGylated micelle nanoparticles 28 . We used laser confocal scanning microscopy to examine the distribution of the UPS 6.9 (free of 64 Cu to avoid radiation exposure) 5 and 60 min after incubation in albumin-containing medium at pH 6.5. HN5 cells were stained for nucleus, cell membrane and lysosomes with Hoechst (blue), anti-F-actin (cyan) and anti-lysosomal-associated membrane protein 1 (green), respectively. Anti-poly(ethylene glycol) antibody was used to label the UPS 6.9 copolymer. Data show the initial adhesion of the copolymer on the cell surface, followed by internalization inside the HN5 cells at 60 min. An image overlay shows the internalized UPS 6.9 punctates colocalized with lysosomes ( Fig. 3e ).
Capture and integration of 64 Cu-UPS 6.9 in the HN5 tumours. Spatiotemporal characterization of 64 Cu-UPS 6.9 distribution in orthotopic HN5 tumours in vivo further validated the capture and integration mechanism. HN5 cancer cells were inoculated in the submental space in the head and neck area of a severe combined immunodeficient mouse. After tumours grew to 100-200 mm 3 , 64 Cu-UPS 6.9 tracer (0.1 mCi) was injected through the tail vein. At 30 min, 3 h and 24 h, animals were sacrificed and tumours were removed and resected into 30-μm-thin slices. Autoradiography analysis showed the initial sporadic capture of 64 Cu-UPS 6.9 in HN5 tumours (mostly at the tumour periphery) at 30 min and 3 h, as verified by haematoxylin and eosin histology, followed by increased tracer accumulation throughout the whole tumour at 24 h ( Supplementary Fig. 6 ).
64 Cu-UPS 6.9 reduced false detection of inflammation by FDG. Non-cancerous tissue inflammation (for example, infection) frequently causes false positive FDG-PET results because inflammatory cells use glucose as a primary source of energy 29 . To compare the imaging response to tissue inflammation by 64 Cu-UPS 6.9 versus FDG, we employed a lipopolysaccharide (LPS)-induced, tumourfree animal model for evaluation. In these experiments, healthy BALB/c mice were used. Two days before PET imaging, LPS was 
pK a -pH injected subcutaneously into the right hind leg of mice to induce inflammation, while phosphate buffered saline (PBS) was injected into the left hind leg as a control. FDG (150 µCi) and 64 Cu-UPS 6.9 (120 µCi) were intravenously injected and imaged 1 and 24 h postinjection, respectively. The FDG signal was significantly higher at the inflammation site (3.4 ± 0.2% of the injected dose per gram of tissue (%ID g −1 ) compared with the normal muscle tissue (0.7 ± 0.2%ID g −1 ; (P < 0.01; Fig. 4 and Supplementary Fig. 7 ). In contrast, 64 Cu-UPS 6.9 showed a slightly increased signal at the LPS injection site (0.56 ± 0.13%ID g −1 ) over the control muscle tissue (0.32 ± 0.05%ID g −1 ), but this difference was not statistically significant. The contrast ratios of inflammation tissue over normal tissue were 4.9 ± 1.3 for FDG and 1.7 ± 0.5 for 64 Cu-UPS 6.9 . The lower contrast ratio by 64 Cu-UPS 6.9 offers a potential advantage via the Cu-UPS 6.9 and 64 Cu-PEG-PLA nanoparticles (both at 25 μg ml −1 ) at pH 6.5 and 7.4 over time. d, Significantly higher cell uptake of UPS 6.9 was found at pH 6.5 compared with pH 7.4, and compared with 64 Cu-PEG-PLA tracers at both pH levels. Data are presented as means ± s.d (n = 3). Statistical significance (***P = 0.0003) was determined by unpaired two-sided Student's t-test, compared with other groups. e, Confocal microscopy showed that UPS 6.9 was mostly bound to cell membranes at 5 min, followed by lysosome colocalization at 60 min after incubation with HN5 cells. Scale bar, 50 μm.
reduction of false positive signals from tissue inflammation normally observed in FDG-PET.
64 Cu-UPS 6.9 achieved binary detection of brain tumours. Brain cancer is one of the most lethal forms of cancer without a widely accepted method for early detection 30 . Late diagnosis when symptoms occur often leads to poor prognosis and survival 31 .
Conventional metabolic PET tracer FDG cannot be used for brain tumour imaging because of the high physiological uptake of glucose in the normal brain tissues 32 . To investigate the feasibility of 64 Cu-UPS 6.9 for glioma detection, we utilized an orthotopic glioma mouse model by transplantation of a green fluorescent protein (GFP)-labelled murine glioma cell line, 73C (astrocytederived gliomas with p53 −/− , PTEN −/− and BRAF V600E mutations), into the stratum of mouse brains. At 24 h after intravenous administration of 64 Cu-UPS 6.9 , PET imaging showed bright illumination of small-sized brain tumours (~10 mm 3 ) over the dark normal brain tissue background ( Fig. 5a and Supplementary  Fig. 8 ). Tissue uptake of 64 Cu-UPS 6.9 was measured at 3.1 ± 1.6 and 0.54 ± 0.3%ID g −1 for 73C tumours and normal brain tissues, respectively. The contrast-to-noise ratio (CNR) was determined to be 15.1 ± 6.8, and the tumour-to-background ratio (TBR) was 6.0 ± 1.6. For comparison, 11 C-methionine (MET)-a newly developed amino acid tracer for brain tumour imaging [33] [34] [35] -was also employed to detect 73C tumours. After intravenous administration, the tissue uptake of MET in tumours was 3.1 ± 0.4%ID g −1 at 20 min. Normal brain tissues had relatively high uptake of MET at 1.9 ± 0.2%ID g −1 , lowering the CNR to 2.8 ± 0.7 and the TBR to 1.6 ± 0.1 compared with 64 Cu-UPS 6.9 ( Supplementary Fig. 9 ).
In the normal brain tissues, the blood-brain barrier was effective at keeping the PEGylated micelle form of 64 Cu-UPS 6.9 out of the brain parenchyma. In 73C gliomas, tumour acidosis was able to activate 64 Cu-UPS 6.9 , leading to significantly increased positron signals. Subsequent investigation of brain tumour slides (8 μm in thickness) by autoradiography and ICG fluorescence correlated microscopically with haematoxylin and eosin histology and GFP fluorescence ( Fig. 5b ). Fluorescence microscopy data further illustrate that the UPS tracer can cross the blood tumour barrier in 73C gliomas and not only accumulate at the perivascular area, but also distribute broadly in the tumour sections (overlay image in Fig. 5c and Supplementary Fig. 10 ). These data corroborate the feasibility of irreversibly trapping UPS tracers in brain cancer cells to achieve binary tumour imaging outcomes at both macroscopic and microscopic levels.
Non-invasive imaging of multiple tumour types by 64 Cu-UPS 6.9 . To investigate the feasibility of 64 Cu-UPS 6.9 to image a broad set of cancers, we evaluated PET imaging of additional head/neck and breast tumour nodules. 64 Cu-UPS 6.9 tracers (0.1 mCi) were injected into the tail vein of tumour-bearing mice. The results show conspicuous detection of occult nodules (10-20 mm 3 ) in orthotopic HN5 and FaDu head and neck tumours, as well as 4T1 triple-negative breast tumours ( Fig. 6a and Supplementary Figs. 9-11 for triplicate reports showing the robustness of tumour detection). Autoradiography images on another set of tumour models with tumour invasion to the surrounding muscles also showed increased accumulation of 64 Cu-UPS in the tumour tissues over the surrounding normal muscles ( Supplementary Fig. 11-13 ). The tissue uptakes were 9.9 ± 2.5, 6.5 ± 2.5 and 5.7 ± 1.2%ID g −1 in the HN5, FaDu and 4T1 tumours 18-24 h after intravenous injection of 64 Cu-UPS 6.9 tracers, respectively. The CNRs were 54.3 ± 8.7, 33.5 ± 3.7 and 34.6 ± 12.1 in the HN5, FaDu and 4T1 tumours (n = 3 for each tumour type), respectively (Fig. 6b ). The TBR values were 21.5 ± 5.6, 16.7 ± 6.0 and 15.6 ± 3.4 in the above three tumour models, respectively. PET imaging using FDG (0.15 mCi) and 64 Cu-PEG-PLA (0.12 mCi) in HN5 tumours showed less striking imaging outcomes. In FDG-PET experiments, despite HN5 tumour contrast (5.4 ± 0.7%ID g −1 ), nonspecific uptake of FDG in the brain (7.9 ± 1.6%ID g −1 ), brown fats (8.1 ± 1.3%ID g −1 ) and tensed muscles (6.3 ± 0.3%ID g −1 ) created false positive signals that complicated tumour diagnosis (Fig. 6a,c and Supplementary Fig. 14) . The high background noise also decreased the CNR value to 1.7 ± 0.6 and the TBR value to 2.0 ± 0.5. In the 64 Cu-PEG-PLA study, a small percentage (2.0 ± 0.2%ID g −1 ) of tumour uptake was observed in HN5 tumours 18-24 h after intravenous injection. The CNR and TBR values of 64 Cu-PEG-PLA (4.4 ± 1.0 and 3.9 ± 0.4, respectively; Fig. 6c and Supplementary  Figs. 15 and 16 ) were significantly lower than for 64 Cu-UPS 6.9 (54.3 ± 8.7 and 21.5 ± 5.6, respectively). These results show that passive targeting through the leaky tumour vasculature is not sufficient to produce high tumour contrast, as shown by the low CNR value of conventional 64 Cu-PEG-PLA micelle probes. To further demonstrate the effect of tumour acidosis, pretreatment of HN5 tumours with acetazolamide-an inhibitor targeting carbonic anhydrase IX (a tumour acidotic protein)-decreased the 64 Cu-UPS 6.9 signals by 30% compared with the PBS control ( Supplementary Fig. 17 ).
Discussion
Biological processes are dynamic and complex, with perpetual changes in space and time. The resulting spatiotemporal heterogeneity makes it challenging to accurately diagnose pathological conditions from normal physiological background. PET or magnetic resonance imaging of acidic tumour microenvironments has been studied extensively in recent years [36] [37] [38] [39] [40] . However, conventional pH sensors have low pH resolution (that is, tenfold signal changes occur over 2 pH units [38] [39] [40] [41] ). Previously, we reported an ICG-based UPS nanoprobe for cancer detection by fluorescence imaging 24 . A binary fluorescent delineation of tumour margins was achieved, which led to accurate cancer surgery and prolonged survival in tumour-bearing mice. The main mechanism was thought to be the coupling of the pH-dependent phase transition phenomenon to the quenching and unquenching of the fluorophores conjugated to the hydrophobic segment of the polymers. In this study, we incorporated a 64 Cu PET functional moiety in the fluorescent nanoparticle formulation. Unlike the on/off fluorescence reporter, the positron signals are always 'on' and cannot be quenched; therefore, phase transition-based changes in signal analogous to fluorescence were not expected. Contrary to expectation, the positron signal showed a binary pattern of background signal suppression and tumour activation similar to the fluorescence output (Figs. 5 and 6). While PET imaging overcomes the light penetration limitations of optical imaging, we were curious about the mechanisms for the unpredicted pattern of the positron signal. Clearly, passive accumulation due to EPR effect alone was not sufficient to produce the high tumour contrast, as indicated by the relatively low CNR and TBR values of 64 Cu-PEG-PLA compared with 64 Cu-UPS in HN5 tumours.
We attribute the dramatically improved sensitivity and specificity of cancer detection by 64 Cu-UPS tracers to a 'capture and integration' mechanism in the acidotic tumour milieu (Fig. 7) . Like most biological signals, tumour acidosis is dynamic, with high intratumoral heterogeneity in space and time. Reversible small molecular pH sensors 42, 43 do not show high tumour contrast due to broad pH responses leading to background activation and incomplete tumour activation. In addition, their signal output varies with the transient fluctuations in tumour metabolism and pH. Other pH tracers, such as the pH (low) insertion peptide (pHLIP), have been reported to undergo a similar capture mechanism by protonation and insertion into the cell membrane in the lower pH environment. However, broad pH responses and strong binding and insertion into blood cells increased background signals with reduced tumour contrast 40 . Consequently, the tumour-to-muscle ratio is around 8 by pHLIP tracers in LNCaP and PC-3 tumours at 24 h postinjection 38 , compared with >30-fold for HN5 tumours by 64 Cu-UPS (Supplementary Table 1 ). For UPS nanoprobes, binary and irreversible activation below a threshold pH (for example, 6.9; readily achievable by a diverse set of tumours 44 ) can permanently convert the spatiotemporal fluctuations of tumour acidotic signals into stable positron output. The sharpness of the phase transition response in this instance resulted in specific retention or capture of the 64 Cu-bearing polymers in acidic tissues such as tumours, while capture was suppressed in the background normal tissue. More specifically, at different time points (t 1 , t 2 ,… t n ), different regions of the tumour could be acidified below the pH threshold (6.9), as indicated by the green spots in the front images in Fig. 7 . This transient acidotic signal in turn activates 64 Cu-UPS micelles circulating at the tumour site into polycationic unimers, which are irreversibly captured, leaving a stable imprint of polymer signal (red spots on the positron map). The irreversible capture resulted in increased dose accumulation over time for 64 Cu-UPS, as validated experimentally ( Supplementary Fig. 6 ). Furthermore, uptake of polymers inside the lysosomes of cancer cells avoids diffusion-caused signal blurring, which may explain the sharp contrast at the tumour and normal tissue boundary even after 24 h. Intact micelles are cleared from the tumour sites, as well as normal tissues through blood circulation. 64 Cu-UPS, by linking the binary activation in response to pH to a novel tissue retention output, suppresses the background while allowing maximum amplification of the tumour signal as approximated by 1 (tumour) or 0 (muscle/brain) outputs.
The data showed that 64 Cu-UPS tracers were able to detect a broad range of occult cancer types (Figs. 5 and 6) in the brain, head and neck, where FDG imaging is obscured by the high signal found in normal brain and tonsil tissues. Moreover, in a non-cancerous, LPS-induced inflammation model, FDG showed significantly increased uptake at LPS-injected muscle sites compared with the normal muscle control, whereas 64 Cu-UPS tracers showed insignificant increases (Fig. 4) . For tumour imaging, although respectable dose accumulation of FDG was observed in tumours (for example, 5.4 ± 0.7%ID g −1 in HN5 tumours), high physiological uptake of FDG in healthy tissues hampers cancer-specific detection of tumours. A similar outcome was also observed in small molecular tracer MET for brain tumour detection, where high normal brain signals lowered tumour contrast compared with 64 Cu-UPS ( Fig. 5 and Supplementary Fig. 9 ). For 64 Cu-UPS, coupling the unique binary output of phase transition to the capture of the acidotic signal allows a more cancer-specific detection of occult diseases ( Fig. 6 ; see also three-dimensional (3D) rotation Supplementary Videos 1-3) . Besides tumour acidosis, other factors, such as leaky tumour vasculature, disrupted blood-brain barriers (as in the case for 73C glioma), elevated micropinocytosis and impaired lymphatics may also contribute to the robust contrast of tumours over surrounding normal tissues by 64 Cu-UPS. Meanwhile, high uptake of 64 Cu-UPS in the reticuloendothelial systems (for example,he liver and spleen) may preclude the use of this agent for the detection of cancers in these organs.
In summary, we report the molecular mechanism of proton transistor-like nanoparticles to capture and integrate tumour acidotic signals into discrete outputs to improve the precision of cancer detection. This represents a second output-tissue retention-coupled to the transistor-like binary behaviour of the UPS nanoparticles besides fluorescence readout. The impact of the concept is illustrated by the non-invasive detection of small occult diseases (10-20 mm 3 or 3-4 mm) in the brain, head/neck and breast by PET imaging. Incorporation of both PET and fluorescence functions in one UPS nanotracer further synergizes two orthogonal imaging modalities, which potentially allows initial whole-body assessment of tumour burden by PET, followed by high-resolution fluorescence imaging for local interventions (for example, biopsy or surgery). We anticipate that the proposed chemical integration mechanism will impact early cancer detection and surveillance while creating strategic insights to incorporate molecular cooperativity principles 45 for the design of precision medicine. methods Synthesis of ICG-and NOTA-conjugated UPS 6.9 nanoprobes and NOTA-PEGb-PLA nanoparticles. The PEG-b-PEPA copolymer was synthesized following the reported procedure using the atom transfer radical polymerization method 24 . The polymers were then dissolved in methanol. ICG-Sulfo-OSu was first added to react with the amino group (1:1 molar ratio) via N-hydroxysuccinimide ester chemistry 46 for 1 h. Next, p-SCN-Bn-NOTA was added to react with the remaining amino group (4:1 molar ratio) overnight at room temperature. Unconjugated ICG and NOTA were removed using Millipore ultrafiltration membranes with a molecular weight cutoff of 10 kDa. The UPS 6.9 nanoprobes were produced via a solvent evaporation method 47 , and concentrated to 5 mg ml −1 for further use.
NOTA-conjugated PEG-b-PLA block copolymers were synthesized by ringopening polymerization following a published procedure 48 . Briefly, polymerization of d,l-lactide was performed at 110 °C using Fmoc-amine-PEG5K-hydroxyl as the macroinitiator and Sn(Oct) 2 as a catalyst. Deprotection of Fmoc was achieved by 20% piperidine in dimethylformamide. After polymer purification with precipitation in ether three times, the solid polymer was suspended in dimethylformamide and reacted with p-SCN-Bn-NOTA at room temperature overnight. Unconjugated NOTA was removed using Millipore ultrafiltration membranes with a molecular weight cutoff of 10 kDa. 64 Cu labelling of UPS 6.9 or PEG-b-PLA nanoprobes. Chelation of 64 Cu 2+ to NOTA on the UPS 6.9 or PEG-b-PLA copolymer was accomplished by adjusting the pH to 6.0-6.5 with 4 M ammonium acetate buffer for 15 min at 37 °C. Micelle formation was carried out by adjusting the solution pH to 7.4 with 2 M sodium carbonate. Removal of unbound 64 CuCl 2 was achieved by centrifugal membrane filtration with a molecular weight cutoff of 100 kD three times. The maximum specific activity of the 64 Cu-UPS nanosensor is 1,860 Ci mmol −1 . Before and after centrifugal filtration, 1 μl of micelle solution was mixed with 8 μl deionized water and 1 μl 50 mM diethylenetriamine pentaacetate for 5 min. A 2 μl mixture was then spotted on a TLC plate and eluted with the mobile phase (PBS). The labelling efficiency was determined by radio-TLC. pH titration and dialysis. UPS 6.9 polymers were first dissolved in 2.5 ml 0.1 M HCl and diluted to 2.0 mg ml −1 with deionized water. Sodium chloride was added to adjust the salt concentration to 150 mM. pH titration was performed by adding small volumes (1 μl in increments) of 4.0 M NaOH solution under stirring. The pH increase in the range of 3-11 was monitored as a function of the total added volume of NaOH. The fully protonated and complete deprotonation states (that is, where the protonation degree equalled 100 and 0%, respectively) were determined by the two extreme-value points of first-derivation pH titration curves. The pH values were measured using a Mettler Toledo pH meter with a microelectrode. Next, UPS 6.9 polymers with a protonation degree of 50% were obtained by adding corresponding volumes of 4.0 M NaOH. Then, 10 ml of polymer solution was centrifuged using an ultracentrifugation tube with a molecular weight cutoff of 100 kDa, to produce ~5 ml of filtrated sample. pH titrations were performed to quantify the amount of polymers and the degree of protonation in both residual and filtrate layers. We repeated the experiments three times and present the results as means ± s.d.
Cell culture. The cancer cell lines used for the in vivo tumour models included HN5, FaDu, human head and neck cancers, 4T1 breast cancers, and GFP-labelled glioma cells with p53 −/− , PTEN −/− and BRAF V600E mutation (also known as 73C glioma cells). The HN5 and FaDu cell lines were obtained from the laboratory of M. Story; the 4T1 cell line was obtained from the laboratory of D. Boothman; and the 73C glioma cells were originally obtained from the laboratory of R. Bachoo at the University of Texas Southwestern. All cells lines were tested for mycoplasma contamination before use. Negative status for contamination was verified using a Mycoplasma Detection Kit from Biotool. Cells were cultured in DMEM or RPMI medium with 10% foetal bovine serum and antibiotics.
Animal models. Animal protocols related to this study were reviewed and approved by the Institutional Animal Care and Use Committee. Female nonobese diabetic and severe combined immunodeficient mice (6-8 weeks of age; ~20 g) were purchased from the University of Texas Southwestern Medical Center Breeding Core. For orthotopic head and neck tumours, HN5 and FaDu (2 × 10 6 mouse −1 ) were injected into the submental triangle area. One week after inoculation, animals with a tumour size of 20-100 mm 3 were used for imaging studies. The orthotopic murine 4T1 breast tumour model was established in female BALB/c mice (6-8 weeks of age, ~20 g) by injection of 4T1 cells (5 × 10 5 mouse −1 ) into the mammary fat pads. The GFP-transfected 73C murine glioma model was established by implanting 10 4 glioma cells intracranially into the striatum (2 mm, 0.5 mm, −2.5 mm; coordinates to the location of tumour cells with respect to the original point at the bregma) of the right hemisphere in male C57BL/6J mice (6-8 weeks of age; ~20 g). Gliomas (2-4 mm in diameter) were formed within 2-3 weeks in mice. The LPS-induced inflammation animal models were established by subcutaneous injection of 50 μg per 20 μl LPS into the right hind leg of BALB/c mice 2 d before the imaging. As a control, 20 μl PBS was injected subcutaneously into the left hind leg of the same mice.
Cell uptake assay. Some 1.5 × 10 4 HN5 cancer cells were seeded into individual wells of 96-well plates (n = 3 for each time point) containing 0.2 ml DMEM media overnight before the nanoprobe incubation. Then, 20 μg ml −1 64 Cu-UPS 6.9 or 64 Cu-PEG-PLA dispersed in either pH 6.5 or pH 7.4 DMEM medium containing 40 mg ml −1 HSA were incubated with HN5 cells. At a specific time point, the cell wells were washed with cold PBS buffer three times to remove all of the non-trapped nanoprobes. Finally, the 96-well plates were exposed on Perkin Elmer storage phosphor screens overnight, then imaged using Typhoon imager for 64 Cu tracer quantification. For confocal imaging, after nanoprobe incubation, the cells were fixed with 4% paraformaldehyde in PBS for 10 min at room temperature, and permeabilized with 0.1% Triton X-100 in PBS for 10 min at 4 °C. Cells were then stained with Hoechst 33342, anti-F-actin and anti-lysosomal-associated membrane protein 1 for nucleus, cell membrane and lysosomes, respectively. Anti-poly(ethylene glycol) antibody was used to label the UPS 6.9 copolymer.
In vivo PET/computed tomography imaging. For 64 Cu-UPS 6.9 , mice received ~100 µCi of nanoprobes in 150 µl saline intravenously via tail vein injection. PET/computed tomography images were acquired 18-24 h postinjection on a Siemens Inveon PET/CT Multi-Modality System for 15 min. For the FDG experiment, mice were fasted for 12 h before PET imaging. Each mouse received 150 µCi FDG in 150 µl saline intravenously via tail vein injection. PET/computed tomography images were acquired 1 h postinjection for 15 min. The mice were sedated on the imaging bed under 2% isoflurane for the duration of imaging. Immediately after the computed tomography data acquisition (performed at 80 kV and 500 μA with a focal spot of 58 μm), 15-min static PET scans were conducted. The PET images were reconstructed using a Fourier rebinning and ordered subsets expectation maximization 3D algorithm. Reconstructed computed tomography and PET images were fused and analysed using Inveon Research Workplace software. PET images were then reconstructed into a single frame using the 3D ordered subsets expectation maximization/maximum a posteriori algorithm. Regions of interest were drawn manually as guided by computed tomography encompassing the tumour in all planes containing the tissue. The target activity was quantitatively calculated as %ID g −1 . The CNR was calculated as 49,50 :
CNR mean activity (tumour) mean activity (background) s d (background)
The background signal was measured as the mean activity in the surrounding normal muscle tissues, with the exception of 73C brain tumours. For 73C gliomas, the background signal was measured from the contralateral normal brain tissues. s.d. (background) refers to the standard deviation of the background tissues. The TBR was calculated as mean activity (tumour)/mean activity (background).
Ex vivo autoradiography and histology. Immediately following PET imaging, the mice were sacrificed, and the tumour and major organs (for example, brain, liver, spleen, heart, kidney, muscle, and so on) were harvested and frozen. Section slides were prepared from each specimen. The slides were first exposed on Perkin Elmer storage phosphor screens, then imaged using Typhoon imager for 64 Cu tracer quantification, followed by fluorescence imaging using a LI-COR Odyssey flatbed scanner with an 800 nm filter for the ICG signal. Finally, haematoxylin and eosin staining was performed for histological correlation of the tumours.
Statistical analysis. Data are expressed as means ± s.d. Sample sizes were chosen to ensure adequate power (>85% at a significance level of P < 0.05) to detect predicted effect sizes, and were estimated on the basis of either preliminary data or previous experiences with similar experiments. Differences between groups were assessed using GraphPad Prism 8, with paired or unpaired two-sided Student's t-tests for the calculation of P values.
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection
The PET images were reconstructed by using a Fourier Rebinning and Ordered Subsets Expectation Maximization 3D (OSEM3D) algorithm. Regions of interest (ROI) were drawn manually as guided by CT encompassing the tumour in all planes containing the tissue. The target activity was quantitatively calculated as percentage injected dose per gram of tissue (%ID/g). The contrast-to-noise ratio was calculated as (tumour mean activity -background mean activity) / background standard deviation.
Data analysis
PET signal quantification was analysed using Inveon Research Workplace (IRW) software. Statistical analyses were performed by GraphPad Prism 8 using paired or unpaired, two-sided Student's t-tests for the calculation of p-values.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
